Zoning Text Amendment (File No. 00988141-PZC)
Summary
SCH Number
2026100515
Public Agency
City of Irvine
Document Title
Zoning Text Amendment (File No. 00988141-PZC)
Document Type
NOE - Notice of Exemption
Received
Posted
10/15/2026
Document Description
Amendment to the Irvine Zoning Ordinance to repeal and replace standards and noticing requirements within Chapters 9-8 and 9-10 pertaining to Research & Development uses that require a conditional use permit in Planning Area 8 as well as uses in the 5.5B Medical & Science zoning district of Planning Area 10 that require a Risk Management Plan (RMP) and expand these requirements to apply citywide to create an Overlay District for all land uses subject to an RMP.
Contact Information
Name
Alyssa Matheus
Agency Name
City of Irvine
Job Title
Planning Manager
Contact Types
Lead/Public Agency / Project Applicant
Phone
Location
Cities
Irvine
Counties
Orange
Regions
Citywide, Southern California
Other Location Info
Citywide
Notice of Exemption
Exempt Status
Other
Type, Section or Code
General Rule Exemption (Section 15061(b)(3))
Reasons for Exemption
The Zoning Ordinance amendment is exempt from the California Environmental Quality Act (CEQA) pursuant to CEQA Guidelines Section 15061(b)(3), which provides that a project is exempt when it is covered by the Common Sense exemption that CEQA only applies to projects which have the potential for causing a significant effect on the environment and does not apply where it can be seen with certainty that there is no possibility of a significant effect. The amendment is limited to establishing an RMP Overlay District and modifying review procedures and noticing requirements for uses that are required to prepare an RMP.
County Clerk
Orange
Attachments
Notice of Exemption
Disclaimer: The Governor’s Office of Land Use and Climate Innovation (LCI) accepts no responsibility for the content or accessibility of these documents. To obtain an attachment in a different format, please contact the lead agency at the contact information listed above. For more information, please visit LCI’s Accessibility Site.